Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02960412 · ClinicalTrials.gov registry record · Phase 4
Effect of Furosemide on Confirmation of Ureteral Patency During Routine Cystoscopy
A Phase 4 study, sponsored by University of South Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
NCT02960412 is a Phase 4 study that has completed, run by University of South Florida. The registered enrollment target is 150 participants.
The verdict
NCT02960412, a Phase 4 study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
Study Summary
This study evaluates if administration of IV furosemide leads to expedited confirmation of ureteral patency when compared to placebo (IV saline) in routine cystoscopy performed after urogynecologic surgery.
Interventions
- DRUG Normal Saline
- DRUG furosemide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2018-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02960412
The ClinicalTrials.gov registry entry for NCT02960412 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal Saline is the first listed.
NCT02960412 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02960412 about?
NCT02960412 is a clinical study titled "Effect of Furosemide on Confirmation of Ureteral Patency During Routine Cystoscopy". This study evaluates if administration of IV furosemide leads to expedited confirmation of ureteral patency when compared to placebo (IV saline) in routine cystoscopy performed after urogynecologic surgery.
What is the current status of trial NCT02960412?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2017-05-01. Estimated completion is 2018-06-30.
What interventions are being tested in trial NCT02960412?
The interventions under investigation include: Normal Saline (DRUG), furosemide (DRUG).
Who is sponsoring clinical trial NCT02960412?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.